Safety and efficacy of drug-eluting stents and bare metal stents in acute coronary syndrome.

Mahmoudi, M, Delhaye, C and Waksman, R (2011) Safety and efficacy of drug-eluting stents and bare metal stents in acute coronary syndrome. Cardiovasc Revasc Med, 12 (6). pp. 385-390.

Full text not available from this repository.

Abstract

Compared with medical therapy, percutaneous coronary intervention has been shown to reduce the rates of death and recurrent ischemia in patients presenting with acute coronary syndromes (ACS). In the current interventional era, both drug-eluting stents (DES) and bare-metal stents (BMS) have been widely used, despite the fact that the use of DES in the context of ACS was initially an "off-label" indication and that ACS has been associated with stent thrombosis (ST). In contrast to the wealth of data available for the use of DES in patients with ST-elevation myocardial infarction, data regarding the performance of DES in non-ST-elevation ACS is restricted to a handful of registries with conflicting data. The aim of this review was to summarize the safety and efficacy of DES in the entire spectrum of ACS.

Item Type:	Article
Divisions :	Surrey research (other units)
Authors :	Name Email ORCID Mahmoudi, M m.mahmoudi@surrey.ac.uk Delhaye, C Waksman, R
Date :	November 2011
DOI :	10.1016/j.carrev.2011.01.001
Uncontrolled Keywords :	Acute Coronary Syndrome, Angioplasty, Balloon, Coronary, Drug-Eluting Stents, Evidence-Based Medicine, Humans, Metals, Prosthesis Design, Risk Assessment, Risk Factors, Stents, Treatment Outcome
Depositing User :	Symplectic Elements
Date Deposited :	17 May 2017 09:47
Last Modified :	24 Jan 2020 17:39
URI:	http://epubs.surrey.ac.uk/id/eprint/825106

Actions (login required)

View Item

Downloads